HomeKZR • NASDAQ
add
Kezar Life Sciences Inc
Previous close
$0.79
Day range
$0.78 - $0.81
Year range
$0.67 - $3.13
Market cap
58.60M USD
Avg Volume
791.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 0.00 | — |
Operating expense | 6.95M | -1.17% |
Net income | -32.26M | -77.44% |
Net profit margin | — | — |
Earnings per share | -0.36 | -43.38% |
EBITDA | -28.12M | -42.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 201.37M | -27.19% |
Total assets | 221.24M | -26.15% |
Total liabilities | 33.66M | 13.37% |
Total equity | 187.57M | — |
Shares outstanding | 72.80M | — |
Price to book | 0.31 | — |
Return on assets | -30.18% | — |
Return on capital | -32.12% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -32.26M | -77.44% |
Cash from operations | -18.98M | -19.50% |
Cash from investing | 27.88M | 421.88% |
Cash from financing | 59.00K | -88.34% |
Net change in cash | 9.00M | 137.48% |
Free cash flow | -6.75M | 32.08% |
About
Founded
2015
Headquarters
Website
Employees
58